Prcc-KO 基因敲除小鼠

1. Linehan, W Marston, Ricketts, Christopher J. 2019. The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications. In Nature reviews. Urology, 16, 539-552. doi:10.1038/s41585-019-0211-5. https://pubmed.ncbi.nlm.nih.gov/31278395/

2. Sun, Cheng, Zhang, Wanqiu, Liu, Hao, Zhai, Zhimin, Hu, Wei. 2024. Identification of a novel lactylation-related gene signature predicts the prognosis of multiple myeloma and experiment verification. In Scientific reports, 14, 15142. doi:10.1038/s41598-024-65937-x. https://pubmed.ncbi.nlm.nih.gov/38956267/

3. Nassar, Amin H, Abou Alaiwi, Sarah, Baca, Sylvan C, Kwiatkowski, David J, Freedman, Matthew L. 2023. Epigenomic charting and functional annotation of risk loci in renal cell carcinoma. In Nature communications, 14, 346. doi:10.1038/s41467-023-35833-5. https://pubmed.ncbi.nlm.nih.gov/36681680/

4. Albiges, Laurence, Guegan, Justine, Le Formal, Audrey, Patard, Jean-Jacques, Escudier, Bernard. 2014. MET is a potential target across all papillary renal cell carcinomas: result from a large molecular study of pRCC with CGH array and matching gene expression array. In Clinical cancer research : an official journal of the American Association for Cancer Research, 20, 3411-21. doi:10.1158/1078-0432.CCR-13-2173. https://pubmed.ncbi.nlm.nih.gov/24658158/

5. Akhtar, Mohammed, Al-Bozom, Issam A, Al Hussain, Turki. . Papillary Renal Cell Carcinoma (PRCC): An Update. In Advances in anatomic pathology, 26, 124-132. doi:10.1097/PAP.0000000000000220. https://pubmed.ncbi.nlm.nih.gov/30507616/

6. Xia, Qiu-Yuan, Wang, Xiao-Tong, Ye, Sheng-Bing, Zhou, Xiao-Jun, Rao, Qiu. 2018. Novel gene fusion of PRCC-MITF defines a new member of MiT family translocation renal cell carcinoma: clinicopathological analysis and detection of the gene fusion by RNA sequencing and FISH. In Histopathology, 72, 786-794. doi:10.1111/his.13439. https://pubmed.ncbi.nlm.nih.gov/29148086/

7. Weterman, M A, Wilbrink, M, Eleveld, M, van Rooijen, M, Geurts van Kessel, A. . Genomic structure, chromosomal localization, and embryonic expression of the mouse homolog of PRCC, a gene associated with papillary renal cell carcinoma. In Cytogenetics and cell genetics, 92, 326-32. doi:. https://pubmed.ncbi.nlm.nih.gov/11435707/

8. Wang, Bo, Yin, Xiaoqin, Gan, Weidong, Han, Xiaodong, Li, Dongmei. 2020. PRCC-TFE3 fusion-mediated PRKN/parkin-dependent mitophagy promotes cell survival and proliferation in PRCC-TFE3 translocation renal cell carcinoma. In Autophagy, 17, 2475-2493. doi:10.1080/15548627.2020.1831815. https://pubmed.ncbi.nlm.nih.gov/33019842/

9. Sidhar, S K, Clark, J, Gill, S, Shipley, J, Cooper, C S. . The t(X;1)(p11.2;q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene. In Human molecular genetics, 5, 1333-8. doi:. https://pubmed.ncbi.nlm.nih.gov/8872474/

10. Weterman, M A, Wilbrink, M, Geurts van Kessel, A. . Fusion of the transcription factor TFE3 gene to a novel gene, PRCC, in t(X;1)(p11;q21)-positive papillary renal cell carcinomas. In Proceedings of the National Academy of Sciences of the United States of America, 93, 15294-8. doi:. https://pubmed.ncbi.nlm.nih.gov/8986805/